<!DOCTYPE html>
<html lang="zh-CN">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0">
    <title>ç§‘ç ”æ—¥æŠ¥ - 2025-12-29</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, "Noto Sans", sans-serif, "Apple Color Emoji", "Segoe UI Emoji";
            line-height: 1.8;
            color: #2c3e50;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            padding: 15px;
            font-size: 16px;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            background: white;
            padding: 35px;
            border-radius: 16px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        }

        /* æ ‡é¢˜ä¼˜åŒ– */
        h1 {
            color: #1a202c;
            font-size: 2em;
            border-bottom: 4px solid #667eea;
            padding-bottom: 15px;
            margin-bottom: 25px;
            font-weight: 700;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            background-clip: text;
        }

        h2 {
            color: #2d3748;
            font-size: 1.5em;
            margin-top: 40px;
            margin-bottom: 20px;
            padding-left: 15px;
            border-left: 5px solid #667eea;
            font-weight: 600;
        }

        h3 {
            color: #4a5568;
            font-size: 1.25em;
            margin-top: 28px;
            margin-bottom: 14px;
            font-weight: 600;
        }

        /* åˆ†ç±»æµè§ˆæŠ˜å åŠŸèƒ½ */
        details {
            margin: 20px 0;
            border-radius: 8px;
            overflow: hidden;
        }

        details summary {
            cursor: pointer;
            padding: 15px 20px;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            color: #2d3748;
            font-size: 1.25em;
            font-weight: 600;
            text-align: right;
            direction: rtl;
            border-right: 5px solid #667eea;
            transition: all 0.3s ease;
            list-style: none;
            user-select: none;
        }

        details summary * {
            direction: ltr;
        }

        details summary::-webkit-details-marker {
            display: none;
        }

        details summary::before {
            content: 'â–¶';
            display: inline-block;
            margin-left: 10px;
            transition: transform 0.3s ease;
            font-size: 0.8em;
        }

        details[open] summary::before {
            transform: rotate(90deg);
        }

        details summary:hover {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            box-shadow: 0 4px 12px rgba(102, 126, 234, 0.3);
        }

        details[open] summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-right-color: white;
        }

        details .details-content {
            padding: 20px;
            background: white;
            border: 1px solid #e9ecef;
            border-top: none;
        }

        h4 {
            color: #718096;
            font-size: 1.1em;
            margin-top: 22px;
            margin-bottom: 12px;
            font-weight: 600;
        }

        p {
            margin-bottom: 16px;
            line-height: 1.8;
        }

        blockquote {
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            border-left: 4px solid #667eea;
            padding: 18px 22px;
            margin: 22px 0;
            border-radius: 8px;
            color: #4a5568;
            font-size: 0.95em;
            box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        }

        blockquote p {
            margin-bottom: 8px;
        }

        blockquote p:last-child {
            margin-bottom: 0;
        }

        blockquote em {
            font-style: normal;
            color: #718096;
            font-size: 0.9em;
        }

        blockquote a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        blockquote a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* é¡¶éƒ¨ç½²åï¼ˆå±…å³ï¼‰ */
        .powered-by-top {
            text-align: right;
            font-size: 0.85em;
            color: #718096;
            font-style: italic;
            margin: 12px 0;
            padding-right: 5px;
        }

        .powered-by-top a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        .powered-by-top a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* AI æ€»ç»“åŒºåŸŸä¼˜åŒ– */
        .ai-summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 28px;
            border-radius: 16px;
            margin: 30px 0;
            box-shadow: 0 12px 35px rgba(102, 126, 234, 0.35);
            position: relative;
            overflow: hidden;
        }

        .ai-summary::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: radial-gradient(circle, rgba(255,255,255,0.1) 0%, transparent 70%);
            pointer-events: none;
        }

        .ai-summary h2 {
            color: white;
            border-left: none;
            border-right: none;
            margin-top: 0;
            margin-bottom: 18px;
            padding-left: 15px;
            padding-right: 0;
            text-align: left;
            direction: ltr;
        }

        .ai-summary h3 {
            color: #f0f0f0;
            margin-top: 18px;
            border-right: 3px solid rgba(255,255,255,0.5);
            padding-right: 12px;
            padding-left: 0;
            text-align: right;
            direction: rtl;
        }

        .ai-summary h3 * {
            direction: ltr;
        }

        .ai-summary blockquote {
            background: rgba(255,255,255,0.15);
            border-left-color: white;
            color: white;
            backdrop-filter: blur(10px);
        }

        .ai-summary p {
            color: white;
        }

        .ai-summary strong {
            color: #fff;
            font-weight: 600;
        }

        ul, ol {
            margin-left: 28px;
            margin-bottom: 18px;
        }

        li {
            margin-bottom: 12px;
            line-height: 1.8;
        }

        /* é“¾æ¥ä¼˜åŒ– */
        a {
            color: #667eea;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: all 0.3s ease;
            font-weight: 500;
        }

        a:hover {
            border-bottom-color: #667eea;
            color: #764ba2;
        }

        /* è¡¨æ ¼ä¼˜åŒ– */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 12px rgba(0,0,0,0.08);
            border-radius: 10px;
            overflow: hidden;
        }

        th, td {
            border: 1px solid #e2e8f0;
            padding: 14px 18px;
            text-align: left;
        }

        th {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            font-weight: 600;
            font-size: 0.95em;
        }

        tr:nth-child(even) {
            background: #f8f9fa;
        }

        tr:hover {
            background: #e9ecef;
            transition: background 0.3s ease;
        }

        /* å…³é”®è¯ç»Ÿè®¡è¡¨æ ¼ç‰¹æ®Šæ ·å¼ï¼ˆæ›´ç´§å‡‘ï¼‰ */
        .keywords-table {
            font-size: 0.9em;
            max-width: 600px;
        }

        .keywords-table th,
        .keywords-table td {
            padding: 10px 14px;
        }

        .keywords-table th {
            font-size: 0.9em;
        }

        hr {
            border: none;
            border-top: 2px solid #e2e8f0;
            margin: 40px 0;
        }

        strong {
            color: #2d3748;
            font-weight: 600;
        }

        code {
            background: #f1f5f9;
            padding: 3px 8px;
            border-radius: 5px;
            font-family: "SF Mono", Monaco, Consolas, "Courier New", monospace;
            font-size: 0.9em;
            color: #e53e3e;
        }

        /* ç¾åŒ–æ»šåŠ¨æ¡ */
        ::-webkit-scrollbar {
            width: 8px;
            height: 8px;
        }

        ::-webkit-scrollbar-track {
            background: #f1f1f1;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb {
            background: #667eea;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb:hover {
            background: #764ba2;
        }

        /* ç§»åŠ¨ç«¯ä¼˜åŒ– */
        @media (max-width: 768px) {
            body {
                padding: 8px;
                font-size: 15px;
            }

            .container {
                padding: 22px 18px;
                border-radius: 12px;
            }

            h1 {
                font-size: 1.6em;
                padding-bottom: 12px;
                margin-bottom: 20px;
            }

            h2 {
                font-size: 1.3em;
                margin-top: 30px;
                padding-left: 12px;
            }

            h3 {
                font-size: 1.15em;
            }

            h4 {
                font-size: 1.05em;
            }

            blockquote {
                padding: 14px 16px;
                margin: 18px 0;
            }

            .ai-summary {
                padding: 20px;
                margin: 22px 0;
            }

            .ai-summary-header {
                flex-direction: column;
                align-items: flex-start;
            }

            .powered-by {
                margin-left: 0;
                margin-top: 8px;
            }

            table {
                font-size: 0.85em;
            }

            th, td {
                padding: 10px 12px;
            }

            .keywords-table {
                font-size: 0.8em;
            }

            .keywords-table th,
            .keywords-table td {
                padding: 8px 10px;
            }

            ul, ol {
                margin-left: 22px;
            }
        }

        /* è¶…å°å±å¹• */
        @media (max-width: 480px) {
            body {
                font-size: 14px;
                padding: 5px;
            }

            .container {
                padding: 18px 14px;
            }

            h1 {
                font-size: 1.4em;
            }

            h2 {
                font-size: 1.2em;
            }

            .ai-summary {
                padding: 16px;
            }

            .powered-by {
                font-size: 0.7em;
            }
        }

        /* å¹³æ»‘æ»šåŠ¨ */
        html {
            scroll-behavior: smooth;
        }

        /* æé«˜å¯ç‚¹å‡»åŒºåŸŸ */
        @media (pointer: coarse) {
            a {
                padding: 4px 0;
                display: inline-block;
            }
        }

        /* æ‰“å°ä¼˜åŒ– */
        @media print {
            body {
                background: white;
                padding: 0;
            }

            .container {
                box-shadow: none;
                max-width: 100%;
            }

            .ai-summary {
                background: #f5f5f5;
                color: black;
                box-shadow: none;
            }

            .ai-summary h2,
            .ai-summary h3,
            .ai-summary p,
            .ai-summary strong {
                color: black;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>ğŸ“… Daily Report - 2025-12-29</h1>
<blockquote>
<p>ä»Šæ—¥ç­›é€‰å‡º <strong>11</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>2</strong> ä¸ªæ¥æº</p>
</blockquote>
<div class="powered-by-top">Powered by <a href="https://kyplus.de" target="_blank" rel="noopener noreferrer">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai" target="_blank" rel="noopener noreferrer">Claude</a></div>

<hr />
<div class="ai-summary">
                <h2>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2>
                <h3>ğŸ§¬ æ•°æ®å‰æ²¿</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
æ­ç¤º3DåŸºå› ç»„ç»„ç»‡åœ¨ç»„ç»‡å†ç”Ÿä¸­çš„åŠŸèƒ½éœ€æ±‚ï¼Œå¹¶å‘ç°PARPä¸KRASG12DæŠ‘åˆ¶å‰‚è”åˆæ²»ç–—åœ¨ä¸¤ç§ä¸åŒç‰©ç§ï¼ˆå°é¼ å’Œäººï¼‰ä¸­å‡èƒ½å¢å¼ºç–—æ•ˆï¼Œæç¤ºæ–°å‹è”åˆç–—æ³•æ½œåŠ›ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- æ¢ç´¢é•¿ç¨‹æŸ“è‰²è´¨ç¯åœ¨ç»„ç»‡å†ç”Ÿä¸­çš„ä½œç”¨ã€‚<br />
- ç ”ç©¶æ¯æºSETDB1å¯¹æ—©æœŸèƒšèƒè½¬å½•ç»„çš„å½±å“ã€‚<br />
- åˆ†æFGFR3é©±åŠ¨çš„åŸºå› è°ƒæ§ç½‘ç»œï¼Œæ­ç¤ºp63åœ¨è†€èƒ±è‚¿ç˜¤ä¸­çš„ä¿ƒç˜¤ä½œç”¨ã€‚<br />
- è¯„ä¼°è‚ é“è…ºç—…æ¯’æŠ—ä½“åœ¨å©´å„¿è¡€æ¸…ä¸­çš„ååº”æ€§ã€‚<br />
- é‰´å®šPARPå’ŒKRASG12DæŠ‘åˆ¶å‰‚è”åˆæ²»ç–—çš„åˆ†å­æœºåˆ¶åŠç–—æ•ˆã€‚<br />
- æ¢ç©¶è¡°è€å®¿ä¸»åœ¨æµæ„Ÿç—…æ¯’æ„ŸæŸ“åè‚ºéƒ¨æ¢å¤å—é˜»çš„å…ç–«æœºåˆ¶ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- ç»“åˆRNA-seqå’ŒHi-CæŠ€æœ¯æ·±å…¥è§£æ3DåŸºå› ç»„ç»„ç»‡ã€‚<br />
- åˆ©ç”¨å•ç»†èƒRNAæµ‹åºï¼ˆscRNA-seqï¼‰æ­ç¤ºç²¾ç»†çš„åˆ†å­æœºåˆ¶ã€‚</p>
<h3>ğŸ§ª åšå®¢æ›´æ–°</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
 UBC Okanagan ç ”ç©¶é¦–æ¬¡è§£ç äº†æ¤ç‰©åˆæˆæŠ—ç™ŒåŒ–åˆç‰© mitraphylline çš„å…³é”®é…¶æœºåˆ¶ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- é˜æ˜ mRNA COVID-19 ç–«è‹—å¼•å‘å¿ƒè‚Œç‚çš„åˆ†å­æœºåˆ¶åŠé™ä½é£é™©çš„ç­–ç•¥ã€‚<br />
- æ­ç¤ºç™Œç»†èƒä¾èµ–çš„ DNA æŸä¼¤åº”æ€¥ä¿®å¤æœºåˆ¶ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- é‰´å®šå‡ºæ¤ç‰©åˆæˆ mitraphylline çš„ä¸¤ä¸ªå…³é”®é…¶ã€‚<br />
- å‘ç° mRNA ç–«è‹—è§¦å‘å¿ƒè‚Œç‚çš„â€œä¸¤æ­¥â€ä¿¡å·é€šè·¯ã€‚</p>
            </div><h2>ğŸ“š åˆ†ç±»æµè§ˆ</h2>
<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (8æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨8æ¡ï¼‰</h4>
<p><strong>1.</strong> <strong>GSE304453 ç»„ç»‡å†ç”Ÿä¸­çš„ 3D åŸºå› ç»„ç»„ç»‡ï¼šé•¿ç¨‹æŸ“è‰²è´¨ç¯çš„åŠŸèƒ½éœ€æ±‚ [RNA-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šRNA-seqã€genome<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Palmira Llorens-Giralt ; Carlos Camilleri-Robles ; Leo Zuber ; Jenisha Khadka ; Maria Marti-Marimon ; Florenci Serras ; Maria C Gambetta ; Marc A Marti-Renom ; Montserrat CorominasSeries Type : Expression profiling by high throughput sequencingOrganism : Drosophila melanogasterThe three-dimensional (3D) organization of the genome plays a fundamental role in gene expression regulation. However, little is known about how transcriptional responses are influenced by changes in genome architecture during tissue regeneration. Here, we used Hi-C to profile 3D chromatin conformation during Drosophila wing imaginal disc regeneration. We found that, although compartments and topologically associating domains (TADs) are largely maintained, regeneration is accompanied by reduced compartmentalization and increased boundary insulation. Notably, we identified three long-range chromatin loops with increased contact frequency during regeneration. Precise deletion of their anchors demonstrated that these loops are essential for proper disc regeneration but dispensable for normal wing development. Furthermore, disruption of any of these loops resulted in convergent changes in both gene expression and H3K4me1 3D environment, suggesting their coordinated activity during regeneration. These findings provide functional evidence that 3D genome architecture actively contributes to the regenerative process.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304453" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>GSE304452 ç»„ç»‡å†ç”Ÿä¸­çš„ 3D åŸºå› ç»„ç»„ç»‡ï¼šé•¿ç¨‹æŸ“è‰²è´¨ç¯çš„åŠŸèƒ½éœ€æ±‚ [Hi-C]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šHi-Cã€genome<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Palmira Llorens-Giralt ; Carlos Camilleri-Robles ; Leo Zuber ; Jenisha Khadka ; Maria Marti-Marimon ; Florenci Serras ; Maria C Gambetta ; Marc A Marti-Renom ; Montserrat CorominasSeries Type : OtherOrganism : Drosophila melanogasterThe three-dimensional (3D) organization of the genome plays a fundamental role in gene expression regulation. However, little is known about how transcriptional responses are influenced by changes in genome architecture during tissue regeneration. Here, we used Hi-C to profile 3D chromatin conformation during Drosophila wing imaginal disc regeneration. We found that, although compartments and topologically associating domains (TADs) are largely maintained, regeneration is accompanied by reduced compartmentalization and increased boundary insulation. Notably, we identified three long-range chromatin loops with increased contact frequency during regeneration. Precise deletion of their anchors demonstrated that these loops are essential for proper disc regeneration but dispensable for normal wing development. Furthermore, disruption of any of these loops resulted in convergent changes in both gene expression and H3K4me1 3D environment, suggesting their coordinated activity during regeneration. These findings provide functional evidence that 3D genome architecture actively contributes to the regenerative process.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304452" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> <strong>GSE269417 å•èƒšèƒæ€»RNAæµ‹åºï¼Œç”¨äºç»˜åˆ¶æ¯æºSETDB1å¯¹2ç»†èƒå’Œ8ç»†èƒè½¬å½•ç»„çš„å½±å“</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsequencingã€transcriptome<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Piroska E SzabÃ³ ; Tie-Bo Zeng ; Zhen FuSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusEmbryos with maternal mutation of the H3K9 methyltransferase SETDB1 die before implantation. We tested the role of maternal SETDB1 in the timely processes of the preimplantation stage embryo. Using single embryo total RNA sequencing from 2-cell and 8-cell embryos, we found that maternal SETDB1 is required for switching off maternal transcripts by the 2-cell stage, minor ZGA transcripts by the 2-cell stage, and major ZGA transcripts by the 8-cell stage. By timely extinguishing of endogenous retroviruses, oocyte-specific ERVL-MaLRs, many oocyte-specific genes, MERVLs, MERVL LTR-driven chimeric transcripts and ZGA genes as well as KRAB ZF genes, maternal SETDB1 secures the proper transition from totipotency to pluripotency.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE269417" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> <strong>GSE314977 åˆ©ç”¨è›‹ç™½è´¨å¾®é˜µåˆ—æµ‹å®š1å²å©´å„¿è¡€æ¸…ä¸­è‚ é“è…ºç—…æ¯’æŠ—ä½“ååº”æ€§</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šantibody<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributor : Jennifer HendrickSeries Type : Protein profiling by protein arrayOrganism : Homo sapiens ; unidentified adenovirusProcessed and raw enteric adenovirus protein microarray reactivity data from 119 year-1 infant serum samples from a Bangladeshi birth cohort, with sample-level metadata aligned to Table 1 of the associated manuscript (Hendrick J, et al. J Infect Dis. 2025; jiaf558. doi:10.1093/infdis/jiaf558).<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314977" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> <strong>GSE314908 Chip-seq æ•°æ®ç”¨äº FGFR3 é©±åŠ¨çš„åŸºå› è°ƒæ§ç½‘ç»œåˆ†æï¼Œæ­ç¤ºäº† p63 åœ¨è…”å†…è†€èƒ±è‚¿ç˜¤ä¸­çš„ä¿ƒè‚¿ç˜¤ä½œç”¨ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šChIP-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Isabelle Bernard-Pierrot ; Xiang-Yu Meng ; Lilia Estrada-Virrueta ; Guerric Gilbert ; Helene Neyret-KahnSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensFGFR3 (Fibroblast Growth Factor Receptor 3) is one of the most frequently altered genes in bladder cancer, primarily through activating mutations that drive oncogenesis and are enriched in luminal tumors. However, the underlying gene regulatory network (GRN) remains poorly characterized. Here, we inferred an FGFR3-mutated GRN using a bottom-up bioinformatics approach, integrating transcriptomic data from bladder cancer cell lines, FGFR3-mutated tumors, and FGFR3-perturbation experiments in human and mouse models. Using CRISPR-Cas9 screen public data, we identified transcription factors (TFs) from this GRN that regulate the viability of FGFR3-mutated cells, with a focus on p63 (TP63). We showed that FGFR3 activation upregulates p63 in patient-derived xenografts and cell lines, while single-cell RNA sequencing revealed heterogeneous p63 activation associated with basal differentiation. Functional studies, including TP63 knock-down in FGFR3-dependent in vitro and in vivo models and RNA-seq along with p63 ChIP-seq, demonstrated that p63 directly promotes cell proliferation and migration, and uncovered a positive feedback loop between FGFR3 and p63. Together, these findings identified p63 as a pro-tumorigenic regulator in FGFR3 mutated tumors despite their luminal differentiation and provide a detailed FGFR3-driven GRN, offering insights into FGFR3-induced oncogenic dependency and potential strategies to circumvent resistance to FGFR inhibitors.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314908" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> <strong>GSE309596 PARP å’Œ KRASG12D æŠ‘åˆ¶å‰‚çš„ç»„åˆé€šè¿‡åˆ©ç”¨å¼±ç‚¹å¢å¼ºæ²»ç–—æ•ˆæœï¼ˆscRNAï¼‰</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šscRNA<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Xin Xu ; Xin Chen ; Rongli Xu ; Min DengSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusCombination of PARP and KRAS G12D Inhibitors Enhances Efficacy Therapeutic Vulnerabilities in PDAC<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309596" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> <strong>GSE279749 PARP å’Œ KRAS G12D æŠ‘åˆ¶å‰‚è”åˆåº”ç”¨å¯å¢å¼ºæ²»ç–—è„†å¼±æ€§çš„ç–—æ•ˆ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šKRAS<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Xin Xu ; Xin Chen ; Rongli Xu ; Ming DengSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensTo elucidate the molecular basis of the HR deficiency induced by KRASG12D inhibition, we conducted RNA sequencing (RNA-seq) on KRASG12D -mutant PDAC cells (AsPC-1, PANC-1, SW1990) treated with MRTX1133 and KRASG12V -mutant CFPAC-1 cell treated with pan-KRAS inhibitor BI-2865. To futher verified the molecular alternation, we also conducted RNA-seq on KRASG12D-mutant Patient-derived xenograft treated with MRTX1133.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279749" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> <strong>GSE271578 åŠ¨åŠ›å­¦å•ç»†èƒRNAæµ‹åºåˆ†ææ­ç¤ºè€å¹´å®¿ä¸»æµæ„Ÿç—…æ¯’æ„ŸæŸ“åè‚ºéƒ¨æ¢å¤å—é˜»çš„å…ç–«æœºåˆ¶</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmune<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Jie Sun ; Yue WuSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusAging is a major risk factor for host morbidity and mortality upon acute respiratory virus infections. To better elucidate the immune determinants of viral pathogenesis during aging, we conducted a time-course single-cell RNA sequencing (scRNAseq) and high-dimensional flow cytometry analysis on the pulmonary responses against influenza infection in young or aged mice. Notably, aged mice exhibited decreased populations of alveolar macrophages (AMs) and dendritic cells (DCs), alongside an increase in monocyte-derived macrophages (MoMs) and interstitial macrophages (IMs), which last weeks after acute viral infection. Additionally, there was enhanced accumulation of respiratory adaptive immune cell cells including tissue resident helper CD4 T cells (TRHs), CD8 tissue resident memory cells (TRMs) and a unique B cell population resembling age-associated B cells. Gene set enrichment analysis (GSEA) comparing lung transcriptomes of young and aged mice across time points highlighted persistent type I and type interferon signaling in aged hosts, especially in the macrophage population. Interestingly, inhibiting interferon signaling in aged mice after viral clearance led to ameliorated long-term sequelae, along with a decrease in IM and TRH populations. Our findings suggest that IFNÎ±/Î³ signaling, particularly in MoM/IM, is pivotal in the development of long-term sequelae following acute respiratory infections in aged hosts.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271578" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§ª åšå®¢æ›´æ–° (3æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨3æ¡ï¼‰</h4>
<p><strong>1.</strong> <strong>ä¸€ç§ç½•è§çš„æŠ—ç™Œæ¤ç‰©åŒ–åˆç‰©ç»ˆäºè¢«ç ´è§£ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šUBC Okanagan researchers have uncovered how plants create mitraphylline, a rare natural compound linked to anti-cancer effects. By identifying two key enzymes that shape and twist molecules into their final form, the team solved a puzzle that had stumped scientists for years. The discovery could make it far easier to produce mitraphylline and related compounds sustainably. It also highlights plants as master chemists with untapped medical potential.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2025/12/251227082728.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>æ–¯å¦ç¦å¤§å­¦ç§‘å­¦å®¶æ­ç¤ºäº†mRNAæ–°å† ç–«è‹—ä¸ºä½•ä¼šå¼•å‘å¿ƒè„ç‚ç—‡ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šinflammation<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šStanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men â€” and how that risk might be reduced. They found that the vaccines can spark a two-step immune reaction that floods the body with inflammatory signals, drawing aggressive immune cells into the heart and causing temporary injury.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2025/12/251227082716.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> <strong>ç™Œç»†èƒä¾èµ–äºä¸€ç§å±é™©çš„DNAä¿®å¤æŠ€å·§</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šResearchers have discovered how cells activate a last-resort DNA repair system when severe damage strikes. When genetic tangles overwhelm normal repair pathways, cells flip on a fast but error-prone emergency fix that helps them survive. Some cancer cells rely heavily on this backup system, even though it makes their DNA more unstable. Blocking this process could expose a powerful new way to target tumors.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2025/12/251227004155.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<h2>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2>
<table class="keywords-table">
<thead>
<tr>
<th>å…³é”®è¯</th>
<th>å‡ºç°æ¬¡æ•°</th>
</tr>
</thead>
<tbody>
<tr>
<td>cancer</td>
<td>2</td>
</tr>
<tr>
<td>genome</td>
<td>2</td>
</tr>
<tr>
<td>inflammation</td>
<td>1</td>
</tr>
<tr>
<td>antibody</td>
<td>1</td>
</tr>
<tr>
<td>ChIP-seq</td>
<td>1</td>
</tr>
<tr>
<td>scRNA</td>
<td>1</td>
</tr>
<tr>
<td>RNA-seq</td>
<td>1</td>
</tr>
<tr>
<td>Hi-C</td>
<td>1</td>
</tr>
<tr>
<td>KRAS</td>
<td>1</td>
</tr>
<tr>
<td>immune</td>
<td>1</td>
</tr>
<tr>
<td>sequencing</td>
<td>1</td>
</tr>
<tr>
<td>transcriptome</td>
<td>1</td>
</tr>
</tbody>
</table>
<hr />
<p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-12-29 03:16</em><br />
<em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p>
    </div>
</body>
</html>